Evidence map›Paper›PMID 37325911›Full record

ArticleEpidemiology and infection2023

Estimates of mpox effective reproduction number in Spain, April-August 2022.

David García-García, Diana Gómez-Barroso, Victoria Hernando, Marta Ruiz-Algueró, Lorena Simón, María Sastre, María José Sierra, Pere Godoy, Asunción Diaz

Abstract read
In one paragraph

Article in Epidemiology and infection, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

David García-GarcíaNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.ORCID 0000-0002-5471-4100
Diana Gómez-BarrosoNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.
Victoria HernandoNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.
Marta Ruiz-AlgueróNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.
Lorena SimónNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.
María SastreNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.
María José SierraCIBER in Infectious Diseases (CIBERINFEC), Madrid, Spain.
Pere GodoyCIBER in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Asunción DiazNational Centre of Epidemiology, Carlos III Health Institute, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analysed the transmission of the human mpox virus in Spain by estimating the effective reproduction number of the disease from official surveillance data. Our computations show that this decreased steadily after an initial burst phase, dropping below 1 on July 12, and thus the outbreak was expected to reduce in the following weeks. Differences in trends were found across geographical regions of the country and across MSM and heterosexual populations.

Indexed as

Mpox, MonkeypoxBasic Reproduction NumberDisease OutbreaksHumansSpainmonkeypoxSpaintransmission

Identifiers

PMID37325911
PMCPMC10369440

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.